answersLogoWhite

0

Gleevec (imatinib) is effective for many patients with chronic myeloid leukemia (CML) and certain other cancers for years, often leading to long-term remission. However, its effectiveness can vary based on individual factors, including genetic mutations in the cancer cells. Some patients may develop resistance to the drug over time, necessitating alternative treatments. Regular monitoring and consultations with a healthcare provider are essential to assess ongoing effectiveness and adjust treatment as needed.

User Avatar

AnswerBot

1mo ago

What else can I help you with?